NYSE:KVUE

Kenvue Stock News

Consumer Defensive > Household & Personal Products

Buy KVUE

*Your capital is at risk

$16.83

-0.490 (-2.83%)

At Close: Jun 03, 2026

Kenvue CEO steps down

06:57am, Monday, 14'th Jul 2025

Tylenol maker Kenvue said on Monday Thibaut Mongon had stepped down as chief executive officer and board member.

Kenvue Announces CEO Transition and Actions to Unlock Shareholder Value

06:45am, Monday, 14'th Jul 2025

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company to unlock shareholder value and reach its ful

Looking to Generate Passive Income? Consider These 3 Rock-Solid Dividend King Stocks

07:15am, Wednesday, 09'th Jul 2025

Investing in the stock market over a long-term time horizon can be an excellent way to compound your savings. However, the path toward unlocking significant gains can be marked by numerous ups and dow

Buy 3 IDEAL Dividend Kings Of 25 'Safer' In July's 55

05:37am, Friday, 04'th Jul 2025

Most Dividend Kings are overpriced, but six currently offer fair value, with annual dividends from $1,000 invested exceeding their share prices. Top-yielding Dividend Kings like Altria, Northwest Natu

The 3 Best Dividend Aristocrats Under $25 to Buy Now With $1000

09:43am, Sunday, 29'th Jun 2025

For younger investors or those on a tight budget, investing in stocks to generate consistent passive income can be daunting because many top dividend stocks trade at prices ranging from $25 to over $1

69 June Aristocrats: 1 To Buy

03:36am, Friday, 20'th Jun 2025

Five of the ten lowest-priced S&P 500 Dividend Aristocrats are currently attractive buys, offering high yields and fair valuations for income investors. Analyst forecasts suggest potential net gains o

Kenvue takeover speculation heats up ahead of M&A window

01:23pm, Monday, 16'th Jun 2025

Kenvue Inc (NYSE:KVUE) is again at the center of takeover speculation as the August expiration of its post–spin-off tax agreement with Johnson & Johnson (NYSE:JNJ) approaches, potentially clearing

Kenvue considering sale of skin and beauty brands to streamline portfolio: report

10:34am, Friday, 13'th Jun 2025

Kenvue Inc (NYSE:KVUE), the consumer health company spun off from Johnson & Johnson (NYSE:JNJ) in 2023, is considering selling a selection of its smaller skin health and beauty brands to streamline th

Kenvue mulls sale of some skin health and beauty brands, sources say

04:09pm, Thursday, 12'th Jun 2025

Kenvue is exploring the sale of some of its skin health and beauty brands, four people familiar with the matter said on Thursday, as the consumer health firm prunes an underperforming business segment

INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Kenvue Inc. and Encourages Long-Term Kenvue Investors to Contact the Firm - KVUE

08:30am, Monday, 09'th Jun 2025

PHILADELPHIA, PA / ACCESS Newswire / June 9, 2025 / Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Kenvue Inc. (NYSE:KVUE) on behalf of the com

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by